While weight-loss aids have been around for decades, a new class of weight-loss drugs, including brands like Ozempic and Wegovy, has soared in popularity. Around one in eight American adults has used ...

Former talk show host Ricki Lake openly discusses her lower face and neck lift, calling it "the best facelift," while ...

Here's why McDonald's is more exposed than other fast-food brands to shifts in eating habits as a result of weight-loss drugs ...

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

Feeling less stigma — not losing weight — was linked to better mental health and eating behaviors after bariatric surgery.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a ...